Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-06 Purchase | 2023-01-10 5:14 pm | Werewolf Therapeutics Inc. | HOWL | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 1,853,000 | $2.21 | $4,095,130 | 6,144,881 (Indirect) | View |
| 2021-12-15 Sale | 2021-12-17 4:17 pm | Werewolf Therapeutics Inc. | HOWL | Leonard Reid Chief Operating Officer | 3,000 | $13.41 | $40,242 | 122,157 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-04 Option Award | 2024-01-04 7:19 pm | N/A 2034-01-03 | Werewolf Therapeutics Inc. | HOWL | Atkins Michael B. Director | 35,000 | $0 | 35,000 (Direct) | View |
Ownership | 2024-01-04 7:13 pm | N/A N/A | Werewolf Therapeutics Inc. | HOWL | Atkins Michael B. Director | 0 | $0 | 14,419 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:40 pm | N/A 2033-12-31 | Werewolf Therapeutics Inc. | HOWL | Trost Timothy W. Chief Financial Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:37 pm | N/A 2033-12-31 | Werewolf Therapeutics Inc. | HOWL | Lubman Ellen Chief Business Officer | 131,900 | $0 | 131,900 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:33 pm | N/A 2033-12-31 | Werewolf Therapeutics Inc. | HOWL | Isaacs Randi Chief Medical Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:30 pm | N/A 2033-12-31 | Werewolf Therapeutics Inc. | HOWL | Karunatilake Chulani Chief Technology Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:30 pm | N/A 2033-12-31 | Werewolf Therapeutics Inc. | HOWL | Seidel-Dugan Cynthia Chief Scientific Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:26 pm | N/A 2033-12-31 | Werewolf Therapeutics Inc. | HOWL | HICKLIN DANIEL J See Remarks | 435,000 | $0 | 435,000 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 5:09 pm | N/A 2033-06-20 | Werewolf Therapeutics Inc. | HOWL | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 13,200 | $0 | 13,200 (Indirect) | View |
| 2023-06-21 Option Award | 2023-06-23 5:07 pm | N/A 2033-06-20 | Werewolf Therapeutics Inc. | HOWL | Morrison Briggs Director | 13,200 | $0 | 13,200 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:53 pm | N/A 2033-06-20 | Werewolf Therapeutics Inc. | HOWL | EVNIN LUKE Director | 13,200 | $0 | 13,200 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:52 pm | N/A 2033-06-20 | Werewolf Therapeutics Inc. | HOWL | Lazarus Alon Director | 13,200 | $0 | 13,200 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:52 pm | N/A 2033-06-20 | Werewolf Therapeutics Inc. | HOWL | DiRocco Derek Director | 13,200 | $0 | 13,200 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:49 pm | N/A 2033-06-20 | Werewolf Therapeutics Inc. | HOWL | Chatterjee Meeta Director | 13,200 | $0 | 13,200 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:48 pm | N/A 2033-06-20 | Werewolf Therapeutics Inc. | HOWL | Sherman Michael A. Director | 13,200 | $0 | 13,200 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-09 9:38 pm | N/A 2032-12-31 | Werewolf Therapeutics Inc. | HOWL | HICKLIN DANIEL J See Remarks | 295,500 | $0 | 295,500 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-09 9:36 pm | N/A 2032-12-31 | Werewolf Therapeutics Inc. | HOWL | Lubman Ellen Chief Business Officer | 86,200 | $0 | 86,200 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-09 9:36 pm | N/A 2032-12-31 | Werewolf Therapeutics Inc. | HOWL | Seidel-Dugan Cynthia Chief Scientific Officer | 115,900 | $0 | 115,900 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-09 9:35 pm | N/A 2032-12-31 | Werewolf Therapeutics Inc. | HOWL | Karunatilake Chulani Chief Technology Officer | 103,600 | $0 | 103,600 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-09 9:35 pm | N/A 2032-12-31 | Werewolf Therapeutics Inc. | HOWL | Trost Timothy W. Chief Financial Officer | 102,800 | $0 | 102,800 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-09 9:34 pm | N/A 2032-12-31 | Werewolf Therapeutics Inc. | HOWL | Leonard Reid Chief Operating Officer | 93,600 | $0 | 93,600 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-09 9:32 pm | N/A 2032-12-31 | Werewolf Therapeutics Inc. | HOWL | Isaacs Randi Chief Medical Officer | 103,300 | $0 | 103,300 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 5:30 pm | N/A 2032-05-31 | Werewolf Therapeutics Inc. | HOWL | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 11,600 | $0 | 11,600 (Indirect) | View |
| 2022-06-01 Option Award | 2022-06-03 4:42 pm | N/A 2032-05-31 | Werewolf Therapeutics Inc. | HOWL | EVNIN LUKE Director | 11,600 | $0 | 11,600 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 4:42 pm | N/A 2032-05-31 | Werewolf Therapeutics Inc. | HOWL | DiRocco Derek Director | 11,600 | $0 | 11,600 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 4:41 pm | N/A 2032-05-31 | Werewolf Therapeutics Inc. | HOWL | Morrison Briggs Director | 11,600 | $0 | 11,600 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 4:40 pm | N/A 2032-05-31 | Werewolf Therapeutics Inc. | HOWL | Karunatilake Chulani Chief Technology Officer | 136,000 | $0 | 136,000 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 4:39 pm | N/A 2032-05-31 | Werewolf Therapeutics Inc. | HOWL | Sherman Michael A. Director | 11,600 | $0 | 11,600 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 4:39 pm | N/A 2032-05-31 | Werewolf Therapeutics Inc. | HOWL | Lazarus Alon Director | 11,600 | $0 | 11,600 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 4:39 pm | N/A 2032-05-31 | Werewolf Therapeutics Inc. | HOWL | Chatterjee Meeta Director | 7,733 | $0 | 7,733 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-18 6:34 pm | N/A 2032-01-05 | Werewolf Therapeutics Inc. | HOWL | Isaacs Randi Chief Medical Officer | 79,516 | $0 | 79,516 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-18 6:33 pm | N/A 2032-01-05 | Werewolf Therapeutics Inc. | HOWL | Leonard Reid Chief Operating Officer | 70,967 | $0 | 70,967 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-18 6:32 pm | N/A 2032-01-05 | Werewolf Therapeutics Inc. | HOWL | Trost Timothy W. Chief Financial Officer | 65,960 | $0 | 65,960 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-18 6:31 pm | N/A 2032-01-05 | Werewolf Therapeutics Inc. | HOWL | HICKLIN DANIEL J See Remarks | 215,888 | $0 | 215,888 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-18 6:30 pm | N/A 2032-01-05 | Werewolf Therapeutics Inc. | HOWL | Lubman Ellen Chief Business Officer | 51,088 | $0 | 51,088 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-18 6:29 pm | N/A 2032-01-05 | Werewolf Therapeutics Inc. | HOWL | Karunatilake Chulani Chief Technology Officer | 34,258 | $0 | 34,258 (Direct) | View |
| 2022-01-12 Exercise | 2022-01-14 5:58 pm | N/A N/A | Werewolf Therapeutics Inc. | HOWL | Seidel-Dugan Cynthia Chief Scientific Officer | 24,199 | $1.56 | 364,972 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-14 5:58 pm | N/A 2032-01-05 | Werewolf Therapeutics Inc. | HOWL | Seidel-Dugan Cynthia Chief Scientific Officer | 79,516 | $0 | 364,972 (Direct) | View |
| 2022-01-12 Exercise | 2022-01-14 5:58 pm | N/A 2030-05-19 | Werewolf Therapeutics Inc. | HOWL | Seidel-Dugan Cynthia Chief Scientific Officer | 39,731 | $0 | 364,972 (Direct) | View |
| 2022-01-12 Exercise | 2022-01-14 5:58 pm | N/A N/A | Werewolf Therapeutics Inc. | HOWL | Seidel-Dugan Cynthia Chief Scientific Officer | 15,532 | $4.77 | 364,972 (Direct) | View |
| 2021-12-30 Exercise | 2022-01-04 4:26 pm | N/A N/A | Werewolf Therapeutics Inc. | HOWL | Leonard Reid Chief Operating Officer | 14,102 | $1.56 | 183,293 (Direct) | View |
| 2021-12-30 Exercise | 2022-01-04 4:26 pm | N/A 2030-05-19 | Werewolf Therapeutics Inc. | HOWL | Leonard Reid Chief Operating Officer | 14,102 | $0 | 183,293 (Direct) | View |